CUSIP 92243G108 · who reports it, how much, and how much it matters to them
34 of the 720 hedge fund managers we track reported shares of Vaxcyte, Inc. (Nasdaq: PCVX) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Ra Capital Management, at USD 667m. The manager with the most riding on it is Kynam Capital Management, where it is 9.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 667m | 5.8% |
| 2 | Deep Track Capital1 fund on PPLI.com | USD 250m | 3.6% |
| 3 | Kynam Capital Management1 fund on PPLI.com | USD 170m | 9.4% |
| 4 | D. E. Shaw & Co.15 funds on PPLI.com | USD 111m | 0.1% |
| 5 | Maverick Capital20 funds on PPLI.com | USD 94m | 0.8% |
| 6 | Polar Capital LLP26 funds on PPLI.com | USD 69m | 0.2% |
| 7 | Adage Capital Management1 fund on PPLI.com | USD 51m | 0.1% |
| 8 | Eversept Partners3 funds on PPLI.com | USD 37m | 1.9% |
| 9 | Boothbay Fund Management2 funds on PPLI.com | USD 31m | 0.4% |
| 10 | Boxer Capital Management1 fund on PPLI.com | USD 19m | 1.4% |
| 11 | Two Sigma Investments35 funds on PPLI.com | USD 16m | 0.0% |
| 12 | Artisan Partners1 fund on PPLI.com | USD 16m | 0.0% |
| 13 | HighVista Strategies27 funds on PPLI.com | USD 8.7m | 2.0% |
| 14 | Millennium Management6 funds on PPLI.com | USD 7.9m | 0.0% |
| 15 | Edgestream Partners5 funds on PPLI.com | USD 7.6m | 0.2% |
| 16 | Superstring Capital Management1 fund on PPLI.com | USD 3.9m | 2.5% |
| 17 | Rock Springs Capital Management2 funds on PPLI.com | USD 3.5m | 0.2% |
| 18 | Bridgewater Associates45 funds on PPLI.com | USD 2.9m | 0.0% |
| 19 | Cormorant Asset Management1 fund on PPLI.com | USD 2.9m | 0.1% |
| 20 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.6m | 0.0% |
| 21 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.5m | 0.0% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 1.9m | 0.0% |
| 23 | Renaissance Technologies13 funds on PPLI.com | USD 1.1m | 0.0% |
| 24 | Cinctive Capital Management5 funds on PPLI.com | USD 1m | 0.0% |
| 25 | Brevan Howard Capital Management39 funds on PPLI.com | USD 984,000 | 0.0% |
| 26 | Persistent Asset Partners10 funds on PPLI.com | USD 878,000 | 0.3% |
| 27 | Aquatic Capital Management3 funds on PPLI.com | USD 808,000 | 0.0% |
| 28 | Landscape Capital Management4 funds on PPLI.com | USD 710,000 | 0.0% |
| 29 | Graham Capital Management18 funds on PPLI.com | USD 646,000 | 0.0% |
| 30 | The Quarry1 fund on PPLI.com | USD 584,000 | 0.0% |
| 31 | Capstone Investment Advisors25 funds on PPLI.com | USD 271,000 | 0.0% |
| 32 | CIBC Asset Management69 funds on PPLI.com | USD 263,000 | 0.0% |
| 33 | Bayforest Capital1 fund on PPLI.com | USD 215,000 | 0.2% |
| 34 | Walleye Capital8 funds on PPLI.com | USD 113,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Kynam Capital Management | USD 170m | 9.4% |
| 2 | Ra Capital Management | USD 667m | 5.8% |
| 3 | Deep Track Capital | USD 250m | 3.6% |
| 4 | Superstring Capital Management | USD 3.9m | 2.5% |
| 5 | HighVista Strategies | USD 8.7m | 2.0% |
| 6 | Eversept Partners | USD 37m | 1.9% |
| 7 | Boxer Capital Management | USD 19m | 1.4% |
| 8 | Maverick Capital | USD 94m | 0.8% |
| 9 | Boothbay Fund Management | USD 31m | 0.4% |
| 10 | Persistent Asset Partners | USD 878,000 | 0.3% |
Vaxcyte, Inc. trades under the symbol PCVX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92243G108.
34 of the 720 hedge fund managers PPLI.com tracks reported Vaxcyte, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 667m), Deep Track Capital (USD 250m), Kynam Capital Management (USD 170m), D. E. Shaw & Co. (USD 111m) and Maverick Capital (USD 94m).
34 managers in our coverage reported it, and between them they run 406 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Kynam Capital Management, where the position was 9.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Vaxcyte, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.